|
1
|
Becker A, Held H, Redaelli M, Chenot JF,
Leonhardt C, Keller S, Baum E, Pfingsten M, Hildebrandt J, Basler
HD, et al: Implementation of a guideline for low back pain
management in primary care: A cost-effectiveness analysis. Spine.
37:701–710. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mirza SK and Deyo RA: Systematic review of
randomized trials comparing lumbar fusion surgery to nonoperative
care for treatment of chronic back pain. Spine. 32:816–823.
2007.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hanley EN Jr, Herkowitz HN, Kirkpatrick
JS, Wang JC, Chen MN and Kang JD: Debating the value of spine
surgery. J Bone Joint Surg Am. 92:1293–1304. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Fassett DR, Kurd MF and Vaccaro AR:
Biologic solutions for degenerative disk disease. J Spinal Disord
Tech. 22:297–308. 2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Miller JA, Schmatz C and Schultz AB:
Lumbar disc degeneration: Correlation with age, sex, and spine
level in 600 autopsy specimens. Spine. 13:173–178. 1988.PubMed/NCBI
|
|
6
|
König SA, Goldammer A and Vitzthum HE:
Anatomical data on the craniocervical junction and their
correlation with degenerative changes in 30 cadaveric specimens. J
Neurosurg Spine. 3:379–385. 2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Luoma K, Riihimäki H, Luukkonen R,
Raininko R, Viikari-Juntura E and Lamminen A: Low back pain in
relation to lumbar disc degeneration. Spine. 25:487–492.
2000.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Leibiger IB and Berggren PO: Sirt1: A
metabolic master switch that modulates lifespan. Nat Med. 12:34–36.
2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Akasaki Y, Alvarez-Garcia O, Saito M,
Caramés B, Iwamoto Y and Lotz MK: FoxO transcription factors
support oxidative stress resistance in human chondrocytes.
Arthritis Rheumatol. 66:3349–3358. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Takayama K, Ishida K, Matsushita T, Fujita
N, Hayashi S, Sasaki K, Tei K, Kubo S, Matsumoto T, Fujioka H, et
al: SIRT1 regulation of apoptosis of human chondrocytes. Arthritis
Rheum. 60:2731–2740. 2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ulakcsai Z, Bagaméry F, Vincze I, Szökő É
and Tábi T: Protective effect of resveratrol against caspase 3
activation in primary mouse fibroblasts. Croat Med J. 56:78–84.
2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Almeida M and Porter RM: Sirtuins and
FoxOs in osteoporosis and osteoarthritis. Bone. 121:284–292.
2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ma CH, Chiua YC, Wu CH, Jou IM, Tu YK,
Hung CH, Hsieh PL and Tsai KL: Homocysteine causes dysfunction of
chondrocytes and oxidative stress through repression of SIRT1/AMPK
pathway: A possible link between hyperhomocysteinemia and
osteoarthritis. Redox Biol. 15:504–512. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yang LJ, Chen Y, He J, Yi S, Wen L, Zhao S
and Cui GH: Effects of gambogic acid on the activation of caspase-3
and downregulation of SIRT1 in RPMI-8226 multiple myeloma cells via
the accumulation of ROS. Oncol Lett. 3:1159–1165. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chauhan D, Bandi M, Singh AV, Ray A, Raje
N, Richardson P and Anderson KC: Preclinical evaluation of a novel
SIRT1 modulator SRT1720 in multiple myeloma cells. Br J Haematol.
155:588–598. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bi TQ, Che XM, Liao XH, Zhang DJ, Long HL,
Li HJ and Zhao W: Overexpression of Nampt in gastric cancer and
chemopotentiating effects of the Nampt inhibitor FK866 in
combination with fluorouracil. Oncol Rep. 26:1251–1257.
2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Benedict C, Shostak A, Lange T, Brooks SJ,
Schiöth HB, Schultes B, Born J, Oster H and Hallschmid M: Diurnal
rhythm of circulating nicotinamide phosphoribosyltransferase
(Nampt/visfatin/PBEF): Impact of sleep loss and relation to glucose
metabolism. J Clin Endocrinol Metab. 97:E218–E222. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Friebe D, Löffler D, Schönberg M, Bernhard
F, Büttner P, Landgraf K, Kiess W and Körner A: Impact of metabolic
regulators on the expression of the obesity associated genes FTO
and NAMPT in human preadipocytes and adipocytes. PLoS One.
6(e19526)2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Laiguillon MC, Houard X, Bougault C,
Gosset M, Nourissat G, Sautet A, Jacques C, Berenbaum F and Sellam
J: Expression and function of visfatin (Nampt), an adipokine-enzyme
involved in inflammatory pathways of osteoarthritis. Arthritis Res
Ther. 16(R38)2014.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Guo JY, Li F, Wen YB, Cui HX, Guo ML,
Zhang L, Zhang YF, Guo YJ and Guo YX: Melatonin inhibits
Sirt1-dependent NAMPT and NFAT5 signaling in chondrocytes to
attenuate osteoarthritis. Oncotarget. 8:55967–55983.
2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Nowell M, Evans L and Williams A:
PBEF/NAMPT/visfatin: A promising drug target for treating
rheumatoid arthritis? Future Med Chem. 4:751–769. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Franco-Trepat E, Alonso-Pérez A,
Guillán-Fresco M, Jorge-Mora A, Gualillo O, Gómez-Reino JJ and
Gómez Bahamonde R: Visfatin as a therapeutic target for rheumatoid
arthritis. Expert Opin Ther Targets. 23:607–618. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Glick D, Barth S and Macleod KF:
Autophagy: Cellular and molecular mechanisms. J Pathol. 221:3–12.
2010.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Rabinowitz JD and White E: Autophagy and
metabolism. Science. 330:1344–1348. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wu JJ, Quijano C, Wang J and Finkel T:
Metabolism meets autophagy. Cell Cycle. 9:4780–4781.
2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Metcalf DJ, García-Arencibia M, Hochfeld
WE and Rubinsztein DC: Autophagy and misfolded proteins in
neurodegeneration. Exp Neurol. 238:22–28. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Caramés B, Taniguchi N, Otsuki S, Blanco
FJ and Lotz M: Autophagy is a protective mechanism in normal
cartilage, and its aging-related loss is linked with cell death and
osteoarthritis. Arthritis Rheum. 62:791–801. 2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Almonte-Becerril M, Navarro-Garcia F,
Gonzalez-Robles A, Vega-Lopez MA, Lavalle C and Kouri JB: Cell
death of chondrocytes is a combination between apoptosis and
autophagy during the pathogenesis of Osteoarthritis within an
experimental model. Apoptosis. 15:631–638. 2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Imai S and Yoshino J: The importance of
NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and
ageing. Diabetes Obes Metab. 15 (Suppl 3):26–33. 2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Imai SI: The NAD World 2.0: The importance
of the inter-tissue communication mediated by
NAMPT/NAD+/SIRT1 in mammalian aging and longevity
control. NPJ Syst Biol Appl. 2(16018)2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yang P, Zhang L, Shi QJ, Lu YB, Wu M, Wei
EQ and Zhang WP: Nicotinamide phosphoribosyltransferase inhibitor
APO866 induces C6 glioblastoma cell death via autophagy. Pharmazie.
70:650–655. 2015.PubMed/NCBI
|
|
34
|
Hsu CP, Hariharan N, Alcendor RR, Oka S
and Sadoshima J: Nicotinamide phosphoribosyltransferase regulates
cell survival through autophagy in cardiomyocytes. Autophagy.
5:1229–1231. 2009.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wang P, Guan YF, Du H, Zhai QW, Su DF and
Miao CY: Induction of autophagy contributes to the neuroprotection
of nicotinamide phosphoribosyltransferase in cerebral ischemia.
Autophagy. 8:77–87. 2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Won Y, Shin Y, Chun CH, Cho Y, Ha CW, Kim
JH and Chun JS: Pleiotropic roles of metallothioneins as regulators
of chondrocyte apoptosis and catabolic and anabolic pathways during
osteoarthritis pathogenesis. Ann Rheum Dis. 75:2045–2052.
2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Heider FC, Mayer HM and Siepe CJ: Lumbar
disc replacement: Update. J Neurosurg Sci. 59:169–180.
2015.PubMed/NCBI
|
|
38
|
Veruva SY, Steinbeck MJ, Toth J, Alexander
DD and Kurtz SM: Which design and biomaterial factors affect
clinical wear performance of total disc replacements? A systematic
review. Clin Orthop Relat Res. 472:3759–3769. 2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhao Y, Luo P, Guo Q, Li S, Zhang L, Zhao
M, Xu H, Yang Y, Poon W and Fei Z: Interactions between SIRT1 and
MAPK/ERK regulate neuronal apoptosis induced by traumatic brain
injury in vitro and in vivo. Exp Neurol. 237:489–498.
2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hong EH, Yun HS, Kim J, Um HD, Lee KH,
Kang CM, Lee SJ, Chun JS and Hwang SG: Nicotinamide
phosphoribosyltransferase is essential for
interleukin-1beta-mediated dedifferentiation of articular
chondrocytes via SIRT1 and extracellular signal-regulated kinase
(ERK) complex signaling. J Biol Chem. 286:28619–28631.
2011.PubMed/NCBI View Article : Google Scholar
|
